yttrium radioisotopes has been researched along with Colorectal Neoplasms in 206 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.46) | 18.7374 |
| 1990's | 13 (6.31) | 18.2507 |
| 2000's | 42 (20.39) | 29.6817 |
| 2010's | 115 (55.83) | 24.3611 |
| 2020's | 33 (16.02) | 2.80 |
| Authors | Studies |
|---|---|
| Bailly, C; Becker, S; Blanc, JF; Boucher, E; Bouvier, A; Chevallier, P; de Baere, T; Edeline, J; Garin, E; Goupil, J; Guiu, B; Manfredi, S; Mariano-Goulart, D; Mastier, C; Patel, B; Pinaquy, JB; Regnault, H; Rode, A; Sefrioui, D; Sengel, C; Somma, C; Tordo, J; Vibert, E; Vicaut, E | 1 |
| Kim, HC | 1 |
| Bilotta, F; d'Andrea, E; Pacilio, M; Russi, M | 1 |
| Entezari, P; Gabr, A; Lewandowski, RJ; Salem, R | 1 |
| Amthauer, H; Böning, G; Franz, K; Gebauer, B; Hardt, J; Kahn, J; Lüdemann, WM; Pustelnik, D; Wieners, G | 1 |
| Albrecht, T; Arnold, D; Bargellini, I; Bilbao, JI; Cianni, R; de Jong, N; Helmberger, T; Kolligs, F; Maleux, G; Munneke, G; Pereira, H; Peynircioglu, B; Sangro, B; Schaefer, N; Zeka, B | 1 |
| Arslan, B; Cieslak, JA; Patel, A; Tasse, JC | 1 |
| Alonso, JC; Casans, I; Espinoza, N; Fuster, D; González, FM; Oyagüez, I; Rodríguez, A; Sánchez, N; Williams, AO | 1 |
| Baker, JC; Borgmann, AJ; Brown, DB; Doyle, PW; Grice, JV; Guys, NP; Huang, S; McGonigle, TW; Shah, N; Taylor, JE; Workman, CS | 1 |
| Fusco, F; Gibbs, P; Gray, AM; Love, S; Moschandreas, J; Sharma, RA; Van Hazel, G; Virdee, PS; Wasan, HS; Wolstenholme, J | 1 |
| Avalos, C; Chao, J; Egelston, CA; Fakih, M; Gozo, MC; Lee, PP; Lim, D; Longmate, JA; Ouyang, C; Park, J; Pillai, R; Sandhu, J; Tajon, M; Wang, C; Yin, HH | 1 |
| Bartenstein, P; Beyer, L; Ilhan, H; Ricke, J; Seidensticker, M; Todica, A; Unterrainer, M | 1 |
| Colaone, F; Hawkins, NS; Pollock, RF; Ross, PJ; Shergill, S; Walter, T | 1 |
| Caponnetto, S; Cianni, R; Cortesi, E; Filippi, L; Gelibter, A; Masi, G; Mezi, S; Pelle, G; Urbano, F | 1 |
| Brennan, VK; Colaone, F; Pollock, RF; Shergill, S | 1 |
| Harders, F; Köhler, M; Masthoff, M; Pascher, A; Rahbar, K; Schindler, P; Schmidt, HH; Stegger, L; Wildgruber, M | 1 |
| Artzner, C; Castaneda Vega, SG; Dittmann, H; Grosse, U; Grözinger, G; Kupferschläger, J; la Fougere, C; Nikolaou, K; Vogel, J; Weissinger, M | 1 |
| Ganguli, S; Goodwin, JS; Kalva, SP; Li, MD; Wehrenberg-Klee, EP; Wu, V; Zurkiya, O | 1 |
| Haber, Z; Hecht, JR; Lee, EW; Padia, SA; Price, M; Sayre, J; Wainberg, Z | 1 |
| Debus, J; Fuxius, S; Giesel, FL; Haberkorn, U; Kratochwil, C; Lindner, T; Rathke, H | 1 |
| Boucher, T; Capanu, M; Carpizo, DR; Cercek, A; Chen, C; Chou, JF; Gendel, V; Jabbour, S; Kemeny, N; Moore, D; Nosher, J | 1 |
| Aparicio, J; Aranda, E; Bilbao, JI; Feliu, J; García-Alfonso, P; Maurel, J; Rodríguez, J; Sangro, B; Vieitez, JM | 1 |
| Bahary, N; Bartlett, DL; Choudry, MHA; Dhir, M; Geller, DA; Hogg, ME; Holtzman, MP; Jones, HL; Pingpank, JF; Tsung, A; Wallis Marsh, J; Zeh, HJ; Zenati, MS; Zureikat, AH | 1 |
| Balkancı, F; Bozkurt, FM; Çil, BE; Eldem, G; Kılıçkap, S; Peynircioğlu, B; Salancı, BV; Türk, G; Yalçın, Ş | 1 |
| Baltatzis, M; Siriwardena, AK | 1 |
| Brzozowski, K; Budzyńska, A; Dziuk, M; Korniluk, J; Mazurek, A; Narloch, J; Piasecki, P; Zięcina, P | 1 |
| Akhter, N; Badiyan, S; Becker, S; Bhooshan, N; Chuong, MD; Etezadi, V; Guerrero, M; Hausner, P; Kaiser, A; Kudryasheva, S; Sharma, N; Yi, BY | 1 |
| Beets-Tan, RGH; Cercek, A; Edward Boas, F; Flynn, J; Gönen, M; Kemeny, NA; Klompenhouwer, EG; Kurilova, I; Petre, EN; Sofocleous, CT; Ulaner, G; Yarmohammadi, H; Ziv, E | 1 |
| Arreaza, JA; Stauffer, JA; Tsamalaidze, L | 1 |
| Abuqbeitah, M; Akgün, E; Akovali, B; Asa, S; Demir, M; Gülsen, F; Sager, S; Sahin, O; Sayman, H; Sönmezoglu, K; Uslu-Beşli, L; Yeyin, N | 1 |
| Alsultan, AA; Barentsz, MW; Koopman, M; Lam, MGEH; Rosenbaum, CENM; Smits, MLJ | 1 |
| Louie, JD; Sze, DY; Wang, DS | 1 |
| Frey, GT; Jia, Z; McKinney, JM; Paz-Fumagalli, R; Sella, DM; Wang, W | 1 |
| Abbott, EM; Able, S; Falzone, N; Hill, MA; Kartsonaki, C; Lee, BQ; Thompson, JM; Vallis, KA | 1 |
| Ghodadra, A; Kim, HS; Lahti, SJ; Magnetta, MJ; Xing, M; Zhang, D | 1 |
| Lentz, RW; Messersmith, WA | 1 |
| Bandula, S; Brown, E; Garin, E; Graham, J; Harris, WP; Herrmann, K; Johnson, MS; Kim, TY; Lewandowski, RJ; Mahvash, A; Martin, RCG; Mills, J; Montazeri, AH; Mulcahy, MF; Padia, SA; Pracht, M; Ross, P; Salem, R; Sinclair, P; Sofocleous, CT; Weaver, A; Wilson, G; Yubero Esteban, A; Zuckerman, D | 1 |
| Ghalambor, TJ; Gholami, S; Langan, RC; McFadden, NR; Perry, LM | 1 |
| Liddell, RP | 1 |
| Edeline, J; Garin, E; Guiu, B; Palard, X; Rolland, Y | 1 |
| Bargellini, I; Bianchi, F; Boni, G; Bozzi, E; Cioni, R; Crocetti, L; Lorenzoni, G; Masi, G; Traino, CA | 1 |
| Abbott, EM; Boardman, P; Denis-Bacelar, AM; Falzone, N; Greenhalgh, TA; Kartsonaki, C; Lee, BQ; McGowan, DR; Sharma, RA; Syed, N; Vallis, KA; Winter, H | 1 |
| Bercu, ZL; Cardona, K; Dabrowiecki, A; Ermentrout, M; Kokabi, N; Newsome, J; Sankhla, T; Shaib, W; Shinn, K | 1 |
| Calatayud, MD; Duch, J; Fondevila, C; Gomez, FM; González, JA; Guerrero, R; Kurilova, I; Pompa, V; Tapias, MA | 1 |
| Bastiaannet, R; Braat, AJAT; Bruijnen, RCG; de Keizer, B; Lam, MGEH; Smits, MLJ; van den Hoven, AF; van Roekel, C | 1 |
| Tomihama, RT | 1 |
| Brodaczewska, K; Brzozowski, K; Dziuk, M; Iller, E; Kieda, C; Kuc, M; Maciak, M; Majewska, A; Mazurek, A; Narloch, J; Piasecki, P; Was, H; Wierzbicki, M; Ziecina, P | 1 |
| Hendlisz, A; Sclafani, F | 1 |
| Ezziddin, S; Hadizadeh, DR; Luetkens, JA; Meyer, C; Sabet, A; Schild, HH; Schmeel, FC; Schmeel, LC; Simon, B; Träber, F | 1 |
| Boas, FE; Bodei, L; Sofocleous, CT | 1 |
| Farrelly, C; Geoghegan, T; Greally, M; Hughes, P; Lawler, LLP; McCaffrey, J; O'Connell, M; O'Leary, C | 1 |
| Benson, B; Carpizo, D; Foltz, GM; Gui, B; Jabbour, SK; Lowenthal, J; Lu, SE; Newman, NB; Nosher, JL; Olsen, JR; Parikh, PJ; Weiner, AA; Yousseff, F; Zuckerman, DA | 1 |
| Beets-Tan, RGH; Boas, FE; Brody, LA; Deipolyi, AR; Gonen, M; Kurilova, I; Petre, EN; Sofocleous, CT; Ulaner, GA; Yarmohammadi, H; Ziv, E | 1 |
| Acuna, SA; Garfinkle, R; Levy, J; Pelletier, JS; Touchette, J; Vanounou, T; Zuckerman, J | 1 |
| Faron, A; Fimmers, R; Kuetting, DLR; Luetkens, JA; Meyer, C; Pieper, CC; Schild, HH; Schmeel, FC; Sprinkart, AM; Thomas, D; Trebicka, J | 1 |
| Adolf, D; Amthauer, H; Dudeck, O; Furth, C; Grosser, OS; Ricke, J; Ruf, J; Stiebler, M; Ulrich, G | 1 |
| Damm, R; Ricke, J; Seidensticker, M; Seidensticker, R | 1 |
| Bilgic, S; Elhan, AH; Gecim, EI; Kucuk, ON; Soydal, C | 1 |
| Carpanese, L; Cosimelli, M; Diodoro, MG; Ercolani, C; Fiore, F; Garufi, C; Giampalma, E; Golfieri, R; Izzo, F; Mancini, R; Melucci, E; Mottolese, M; Pizzi, G; Sciuto, R; Sperduti, I | 1 |
| Bagni, O; Chiacchiararelli, L; Chiaramida, P; Cianni, R; D'Arienzo, M; Filippi, L; Salvatori, R; Scopinaro, F | 1 |
| Bartenstein, P; Fendler, WP; Hacker, M; Haug, AR; Heinemann, V; Ilhan, H; Jakobs, TF; Paprottka, PM; Philippe Tiega, DB | 1 |
| Frizelle, FA; Stiven, P | 1 |
| Amthauer, H; Großer, O; Ricke, J | 1 |
| Koopman, M; Lam, MG; Nijsen, JF; Rosenbaum, CE; Smits, ML; van den Bosch, MA; van den Hoven, AF; Zonnenberg, BA | 1 |
| Law, MW; Lee, VH; Leung, TW; Liu, RK; Ma, VW; Ng, SC; Tso, WK | 1 |
| Goris, ML; Iagaru, AH; Lam, MG; Louie, JD; Mittra, ES; Sze, DY | 1 |
| Kao, YH | 1 |
| Amthauer, H; Grosser, OS; Ricke, J | 1 |
| Bester, L; Gibbs, P; Meteling, B; Morris, DL; Perera, M; Saxena, A; Shan, L | 1 |
| Carpizo, DR; Gendel, VM; Gensure, RH; Greene, SJ; Jabbour, SK; Moore, DF; Nosher, JL; Yu, X | 1 |
| Brody, LA; Capanu, M; Carrasquillo, JA; Chou, JF; Do, KG; Garcia, AR; Kemeny, NE; Longing, AP; Pandit-Taskar, N; Petre, EN; Sofocleous, CT | 1 |
| Annunziata, S; Caldarella, C; Galiandro, F; Treglia, G | 1 |
| Atassi, B; Atassi, R; Benson, AB; Desai, K; Gates, VL; Habib, A; Hickey, R; Hohlastos, E; Kircher, S; Lewandowski, RJ; Marshall, K; Memon, K; Mulcahy, MF; Newman, SB; Nimeiri, H; Salem, R; Salzig, K; Sato, K; Vouche, M; Williams, M | 1 |
| Bauman, M; Kikolski, SG; Morshedi, MM; Rose, SC | 1 |
| Dutton, SJ; Kenealy, N; Love, SB; Sharma, RA; Wasan, HS | 1 |
| Arbizu, J; Domínguez-Prado, I; Elosúa, C; García-Velloso, MJ; Martí-Climent, JM; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Fraile, M; Vigil, C | 1 |
| Amesur, N; Chalhoub, D; Geller, DA; Marsh, JW; McDonald, KA; Orons, P; Sukato, D; Tohme, S; Tsung, A; Zajko, A | 1 |
| Bester, L; Golani, S; Kapoor, J; Meteling, B; Morris, DL; Saxena, A | 1 |
| Aouf, A; Biersack, HJ; Ezziddin, S; Ghamari, S; Mayer, K; Meyer, C; Pieper, CC; Sabet, A | 1 |
| Hickey, R; Lewandowski, R; Salem, R | 1 |
| Blaszkowsky, LS; Dave, B; Ganguli, S; Kalva, SP; Kwak, E; Liu, R; Rabito, C; Rachamreddy, N; Rana, RS; Sharma, A | 1 |
| Lee, EW; Liu, DM; Tafti, BA; Thakor, AS | 1 |
| Cade, DN; Gebski, V; Gibbs, P; Thurston, K; Van Buskirk, M; Van Hazel, GA | 1 |
| Bartenstein, P; Fendler, WP; Goritschan, A; Hacker, M; Haug, AR; Ilhan, H; Jakobs, TF; Paprottka, P | 1 |
| Angelelli, B; Cappelli, A; Galaverni, MC; Giampalma, E; Golfieri, R; Mazzarotto, R; Monari, F; Mosconi, C; Pettinato, C; Pinto, C; Renzulli, M | 1 |
| Abbott, AM; Almhanna, K; Arslan, B; Biebel, B; Choi, J; El-Haddad, G; Fulp, WJ; Hoffe, SE; Kim, R; Kis, B; Meredith, KL; Shibata, D; Shridhar, R; Strosberg, J; Sweeney, J | 1 |
| Akehurst, R; Bester, L; Kennedy, AS; Pennington, B; Sangro, B; Sennfält, K; Wasan, H | 1 |
| Kim, HS; Lahti, SJ; Lee, JJ; Magnetta, MJ; Xing, M; Zhang, D | 1 |
| Camacho, JC; Kim, HS; Kokabi, N; Lahti, S; Schuster, DM; Xing, M | 1 |
| Alago, W; Brody, LA; Carrasquillo, JA; D'Angelica, MI; Do, RK; Gonen, M; Kemeny, NE; Osborne, JR; Pandit-Taskar, N; Petre, EN; Segal, NH; Shady, W; Sofocleous, CT; Sotirchos, VS; Violari, EG | 1 |
| Delu, A; Deming, P; Henrie, AM; Wittstrom, K | 1 |
| Camacho, JC; Edalat, F; Galt, JR; Kendi, AT; Kim, HS; Kokabi, N | 1 |
| Ball, DS; Cohen, SJ; Cohn, M; Coldwell, D; Drooz, A; Ehrenwald, E; Kanani, S; Kennedy, AS; Moeslein, FM; Nutting, CW; Putnam, SG; Rose, SC; Savin, MA; Schirm, S; Sharma, NK; Wang, EA | 1 |
| Carrasquillo, JA; Chalasani, S; Cheal, SM; Cheung, NV; Fung, EK; Guo, HF; Jungbluth, A; Larson, SM; Lee, SG; O'Donoghue, J; Punzalan, B; Smith-Jones, PM; Wittrup, KD; Xu, H; Zanzonico, PB | 1 |
| Aerts, R; De Hertogh, G; Deroose, C; Haustermans, K; Heye, S; Laenen, A; Maleux, G; Prenen, H; Sagaert, X; Topal, B; Van Cutsem, E; Vanbeckevoort, D; Vandecaveye, V; Verslype, C | 1 |
| Abbott, A; Baigorri, B; Benson, AB; Boyer, B; Critchfield, J; Ehrenwald, E; Gabr, A; Gates, VL; Geschwind, JF; Gorodetski, B; Hickey, R; Kallini, J; Kauffman, S; Kircher, S; Kwan, S; Lewandowski, RJ; Mulcahy, M; Nimeiri, H; Padia, SA; Prudhomme, T; Rilling, WS; Salem, R; Shridhar, R; White, SB | 1 |
| Gulec, SA | 1 |
| Alavi, A; de Jong, HW; Elias, SG; Koopman, M; Lam, MG; Rosenbaum, CE; van den Bosch, MA; van den Hoven, AF; Verkooijen, HM | 1 |
| Kennedy, AS | 1 |
| Fendler, WP; Ilhan, H; Jakobs, TF; Lehner, S; Paprottka, KJ; Paprottka, PM; Raeßler, F; Sommer, W; Strobl, F; Trumm, CG | 1 |
| Akinwande, O; Hahl, M; Kelly, L; Martin, RC; McMasters, KM; Philips, P; Scoggins, CR; Tatum, C | 1 |
| Hickey, R; Lewandowski, RJ; Nimeiri, H; Salem, R; Sangha, BS | 1 |
| Boas, FE; Do, RK; Gavane, S; Gonen, M; Kishore, S; Osborne, JR; Shady, W; Sofocleous, CT; Ulaner, GA; Ziv, E | 1 |
| Boas, FE; Brody, LA; Erinjeri, JP; Kishore, S; Shady, W; Sofocleous, CT; Yarmohammadi, H | 1 |
| Ezziddin, S; Hadizadeh, DR; Luetkens, JA; Sabet, A; Schild, HH; Schmeel, FC; Schmeel, LC; Simon, B; Träber, F | 1 |
| Carrasquillo, JA; Do, RK; Gonen, M; Pandit-Taskar, N; Shady, W; Sofocleous, CT; Sotirchos, VS | 1 |
| Amthauer, H; Breier, L; Damm, R; Garlipp, B; Mohnike, K; Pech, M; Ricke, J; Seidensticker, M; Seidensticker, R; Steffen, IG; Ulrich, G | 1 |
| Alsaikhan, N; Ball, DS; Cohen, SJ; Cohn, M; Coldwell, DM; Drooz, A; Ehrenwald, E; Hoh, CK; Kanani, S; Kennedy, AS; Minocha, J; Moeslein, FM; Narsinh, KH; Nutting, CW; Putnam, SG; Rose, SC; Savin, MA; Schirm, S; Sharma, NK; Suhail, M; Thurston, K; Van Buskirk, M; Wang, EA | 1 |
| Chong, LC; Karapetis, C; Price, TJ; Townsend, AR | 1 |
| Bartlett, DL; Chung, MH; Doherty, MG; Marsh, JW; Varma, MK; Wright, GP | 1 |
| Banovac, F; Chasovskikh, S; Dritschilo, A; Goldberg, M; Janowski, E; Kim, A; Pang, D; Timofeeva, O; Unger, K | 1 |
| Chao, C; Dagli, M; Mondschein, JI; Nadolski, G; Soulen, MC; Stavropoulos, SW; Sudheendra, D | 1 |
| Dehm, K; Helmberger, TK; Hoffmann, RT; Jakobs, TF; La Fougere, C; Murthy, R; Reiser, MF; Stemmler, HJ; Tatsch, K; Trumm, C | 1 |
| Delatte, P; El Nakadi, I; Flamen, P; Hendlisz, A; Larsimont, D; Liberale, G; Van den Eynde, M | 1 |
| Ameye, L; Delatte, P; Flamen, P; Ghanem, G; Hendlisz, A; Van Den Eynde, M; Vanderlinden, B | 1 |
| Lam, MG; Nijsen, JF; van den Bosch, MA; van der Tweel, I; van Het Schip, AD; Vente, MA; Wondergem, M; Zonnenberg, BA | 1 |
| Georgiades, CS; Geschwind, JF; Herman, JM; Hong, K; Kamel, IR; McBride, JD; Reyes, DK | 1 |
| Atassi, B; Benson, A; Ibrahim, SM; Lewandowski, RJ; Mulcahy, MF; Newman, S; Omary, RA; Ryu, RK; Salem, R; Sato, KT; Talamonti, M | 1 |
| Helmberger, TK; Hoffmann, RT; Jakobs, TF; Kubisch, CH; Reiser, MF; Stemmler, HJ; Tatsch, K; Trumm, C | 1 |
| Burmeister, J; Campbell, JM; Joiner, M; Marples, B; Muzik, O; Wong, CO | 1 |
| Bilbao, JI; Goffette, P; Jamar, F; Lhommel, R; Pauwels, S; Van den Eynde, M; Walrand, S | 1 |
| Cianni, R; Cortesi, E; Dornbusch, T; Notarianni, E; Pasqualini, V; Saltarelli, A; Salvatori, R; Urigo, C | 1 |
| Ellis, S; Hahl, M; Martin, RC; McMasters, K; Scoggins, CR; Tatum, C; Whitney, R | 1 |
| Karapetis, C; Price, T; Townsend, A | 1 |
| Berry, DP; Nicolay, NH; Sharma, RA | 1 |
| Beyer, T; Brechtel, K; Dittmann, H; Kupferschläger, J; Pfannenberg, C; Werner, MK | 1 |
| Deleporte, A; Flamen, P; Hendlisz, A | 1 |
| Haydar, AA; Tait, P; Wasan, H; Wilson, C | 1 |
| Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY | 1 |
| Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK | 1 |
| Amthauer, H; Dudeck, O; Fischbach, F; Grosser, O; Pech, M; Ricke, J; Rühl, R; Schulmeister, A; Wieners, G; Wybranski, C; Zeile, M | 1 |
| De Keukeleire, K; Defreyne, L; Delatte, P; Delaunoit, T; Flamen, P; Hendlisz, A; Lambert, B; Maleux, G; Paesmans, M; Peeters, M; Personeni, N; Van Cutsem, E; Van den Eynde, M; Van Laethem, JL; Vannoote, J; Verslype, C | 1 |
| Angelelli, B; Bacchetti, S; Cagol, PP; Carpanese, L; Cosimelli, M; Diodoro, MG; Fiore, F; Gasperini, D; Geatti, O; Giampalma, E; Golfieri, R; Izzo, F; Lastoria, S; Maini, CL; Mancini, R; Perrone, M; Pizzi, G; Sciuto, R; Sperduti, I | 1 |
| Akther, J; Bester, L; Chua, TC; Morris, DL | 1 |
| Bester, L; Goldstein, D; Sjoquist, KM | 1 |
| Illidge, T; Jeans, S; Laasch, HU; Lawrance, JA; Murphy, G; Omed, A; Tipping, J; Wilson, G; Zivanovic, M | 1 |
| Al-Nahhas, A; Gordon, F; Habib, N; Hodolic, M; Karunanithy, N; Tait, NP; Wasan, HS | 1 |
| Bester, L; Chua, TC; Morris, DL; Saxena, A | 1 |
| Benito, A; Bilbao, JI; Iñarrairaegui, M; Rodríguez, M; Sangro, B | 1 |
| Chang, CY; Chao, LS; Huang, PI; Lee, RC; Lin, KH; Liu, CS; Liu, RS; Oliver Wong, CY; Tseng, HS; Tung, CJ; Wang, LW; Wang, SJ; Yen, SH | 1 |
| Kee, ST; Lee, EW; Liu, DM; Loh, CT; McWilliams, JP | 1 |
| Coldwell, D; Kennedy, A; Salem, R; Sangro, B; Wasan, H | 1 |
| Boutros, C; Espat, NJ | 1 |
| Forero, A; LoBuglio, AF; Meredith, RF; Shen, S | 1 |
| Barot, TC; Gulec, SA; Pennington, K; Suthar, RR | 1 |
| Dowling, R; Gibbs, P; Kosmider, S; Lichtenstein, M; Tan, TH; Yip, D | 1 |
| de Baere, T; Deschamps, F | 1 |
| Amthauer, H; Denecke, T; Dudeck, O; Fahlke, J; Hildebrandt, B; Kettner, E; Kraus, P; Mohnike, K; Pech, M; Ricke, J; Seidensticker, M; Seidensticker, R | 1 |
| Geschwind, JF; Pellerin, O | 1 |
| Antoch, G; Bockisch, A; Ertle, J; Gerken, G; Hamami, M; Heusner, TA; Lauenstein, TC; Schlaak, JF | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Katagiri, T; Nakagawa, H; Nakamura, Y; Oriuchi, N; Osawa, R; Paudyal, P; Shiba, Y; Tominaga, H; Tsunoda, T; Yamamoto, S; Yoshida, K; Yoshioka, H | 1 |
| Bekaii-Saab, T; Blazer, M; Bloomston, M; Cucci, A; Khabiri, H; Martin, LK; Rose, J; Schmidt, C; Wei, L | 1 |
| Seront, E; Van den Eynde, M | 1 |
| Chalian, H; Tochetto, SM; Töre, HG; Yaghmai, V | 1 |
| Barot, TC; Gulec, SA; Hall, M; Pennington, K; Schwartzentruber, D; Suthar, RR; Wheeler, J | 1 |
| Al-Nahhas, A; Ariff, B; Barwick, T; Habib, N; Hatice, G; Tait, P; Towey, D; Wasan, H; Zerizer, I | 1 |
| Huijbregts, JE; Koopman, M; Lam, MG; Rosenbaum, CE; van den Bosch, MA; Veldhuis, WB | 1 |
| Hill, EJ; Jani, AR; Sharma, RA; Wang, LM | 1 |
| Gensure, RH; Haffty, BG; Jabbour, SK; Narra, V; Nosher, JL; Patel, B; Schonewolf, CA | 1 |
| Chu, DZ; Doroshow, JH; Ikle, DN; Kwok, CS; Liu, A; Raubitschek, AA; Shibata, S; Shively, JE; Wilczynski, S; Williams, LE; Wong, JY; Wu, AM; Yamauchi, DM; Yazaki, PJ | 1 |
| Blumenthal, RD | 1 |
| Bleichrodt, RP; Boerman, OC; Goldenberg, DM; Koppe, MJ; Oyen, WJ; Soede, AC; Verhofstad, AA | 1 |
| Barker, D; Dworkin, HJ; Gates, V; Hill, EA; Lewandowski, R; Nagle, C; Qing, F; Salem, R; Wong, CY; Wong, KT | 1 |
| Coldwell, D; Drachenberg, C; Gaiser, J; Kennedy, AS; Nutting, C | 1 |
| Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M | 1 |
| Bailey, W; Dowling, R; Gibbs, P; Liechtenstein, M; Lim, L; Little, A; Shapiro, JD; Smith, D; Yip, D | 1 |
| Ahrar, K; Barron, B; Cohen, AC; Gupta, S; Hicks, ME; Madoff, DC; Murthy, R; Nunez, R; Szklaruk, J; Wallace, MJ; Xiong, H | 1 |
| Abe, M; Baranowska-Kortylewicz, J; Enke, CA; Kortylewicz, ZP; Kurizaki, T; Mosley, RL; Nearman, J; Ostman, A; Paulsson, J; Pietras, K | 1 |
| Gates, VL; Geschwind, JF; Goin, JE; Lewandowski, RJ; Salem, R; Thurston, KG; Van Buskirk, M; Wong, CY | 1 |
| Coldwell, D; Kennedy, AS; Loehr, SP; Meranze, S; Murthy, R; Niedzwiecki, J; Nutting, C; Overton, C; Sailer, S; Wertman, DE | 1 |
| Correia, MM; O'Brien, I; Stubbs, RS | 1 |
| Kennedy, AS; Thomadsen, B; Welsh, JS | 1 |
| Al-Nahhas, A; Canelo, R; Habib, N; Jiao, L; Pagou, M; Szyszko, T; Tait, P; Wasan, H | 1 |
| Berry, DP; Blanshard, K; Bower, G; Gibbs, P; Morgan, B; Price, D; Shannon, JA; Sharma, RA; Steward, WP; Van Hazel, GA | 1 |
| Al-Nahhas, A; Bansi, D; Canelo, R; Habib, NA; Jiao, LR; Limongelli, P; Lowdell, C; Philips, R; Rubello, D; Stamp, G; Szyszko, T; Tait, P; Thillainayagam, A; Wasan, H; Woo, K | 1 |
| Blend, MJ; Bui, JT; Espat, NJ; Garrean, S; Helton, WS; Muhs, A; Owens, C | 1 |
| Buckland, ME; Gilbert, DR; Newland, LR; Walsh, A | 1 |
| Helmberger, TK; Hoffmann, RT; Jakobs, TF; Reiser, MF; Tatsch, K; Trumm, C | 1 |
| Canet, S; Eng, C; Habbu, A; Hicks, ME; Krishnan, S; Madoff, DC; Murthy, R | 1 |
| Amthauer, H; Denecke, T; Grieser, C; Hildebrandt, B; Lopez Hänninen, E; Plotkin, M; Podrabsky, P; Ricke, J; Rühl, R; Stelter, L; Stiepani, H; Werk, M | 1 |
| Abdel-Misih, R; Dignazio, M; Garcia, M; Khatri, J; Neff, R; Petrelli, N; Wilson, P | 1 |
| Price, TJ; Townsend, A | 1 |
| Esteban, JM; Johnson, DK; Neumaier, M; Odom-Maryon, T; Primus, FJ; Shively, JE; Williams, LE; Wong, JY; Wu, AM; Yamauchi, DM | 1 |
| Burton, MA; Gray, BN | 1 |
| Ackermann, RJ; Andrews, JC; Cotton, LA; Ensminger, WD; Shapiro, B; Walker, SC | 1 |
| Adair, JR; Antoniw, P; Baker, TS; Farnsworth, AP; Finney, H; Haines, AM; King, DJ; Lawson, AD; Lyons, A; Owens, RJ | 1 |
| Appelbaum, FR; Bernstein, ID; Eary, J; Haines, AM; Hamann, P; Hinman, L; Howell-Clark, J; King, DJ; Matthews, D; Press, OW; Shan, D; Shochat, D | 1 |
| Antoniw, P; Farnsworth, AP; Haines, AM; Humm, J; King, DJ; Mackintosh, J; Mountain, A; Old, LJ; Shochat, D; Turner, A; Welt, S; Yarranton, GT | 1 |
| Begent, RH; Casey, JL; Chaplin, LC; Haines, AM; King, DJ; Mountain, A; Pedley, RB; Yarranton, GT | 1 |
| Chan, KW; Chan, M; Ho, S; Johnson, PJ; Lau, WY; Lee, WY; Leung, TW; Li, AK | 1 |
| Begent, RH; Boden, JA; Boden, R; Casey, JL; Chaplin, LC; Dorning, M; King, DJ; Pedley, RB | 1 |
| Begent, RH; Casey, JL; Green, AJ; King, DJ; Pedley, RB; Yarranton, GT | 1 |
| Endo, K; Inoue, T; Kim, EE; Kuroki, M; Matsuoka, Y; Murata, H; Oriuchi, N; Sasaki, Y; Tanada, S; Watanabe, N | 1 |
| Chu, DZ; Doroshow, JH; Liu, A; Raubitschek, AA; Shively, JE; Wilczynski, S; Williams, LE; Wu, AM; Yamauchi, DM | 1 |
| Begent, RH; Boden, R; Boxer, GM; Flynn, AA; Green, AJ; Pedley, RB | 2 |
| Anderson, J; Burton, M; Gebski, V; Gray, B; Hope, M; Moroz, P; Van Hazel, G | 1 |
| Herba, MJ; Thirlwell, MP | 1 |
| Begent, RH; Bhatia, J; Boden, R; Boxer, GM; Flynn, AA; Green, AJ; Morris, R; Pedley, RB | 1 |
| Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
| Anderson, JH; Bessent, RG; Cooke, TG; Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Stewart, I | 1 |
| Byrd, BL; Crook, JE; Holloway, EC; Lee, YC; Steplewski, Z; Sun, TT; Washburn, LC | 1 |
| Beatty, BG; Beatty, JD; Paxton, RJ; Shively, JE; Williams, LE; Wong, JY | 1 |
| Anderson, J; Burton, MA; Gray, BN; Kelleher, DK; Klemp, P | 1 |
| Atri, M; Boos, GJ; Bret, PM; Herba, MJ; Illescas, FF; Rosenthall, L; Thirlwell, MP | 1 |
| Byrd, B; Crook, JE; Lee, YC; Stabin, MG; Steplewski, Z; Sun, TT; Washburn, LC | 1 |
32 review(s) available for yttrium radioisotopes and Colorectal Neoplasms
| Article | Year |
|---|---|
Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases: A Systematic Review of Clinical Evidence.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Prospective Studies; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Pneumonectomy; Yttrium Radioisotopes | 2022 |
Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Female; Humans; Liver Neoplasms; Microspheres; Pregnancy; Yttrium Radioisotopes | 2023 |
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Colorectal Neoplasms; Double-Blind Method; Drug Combinations; Humans; Microspheres; Neoplasm Metastasis; Network Meta-Analysis; Palliative Care; Phenylurea Compounds; Progression-Free Survival; Pyridines; Pyrrolidines; Randomized Controlled Trials as Topic; Thymine; Trifluridine; Uracil; Yttrium Radioisotopes | 2020 |
Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.
Topics: Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Retreatment; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review.
Topics: Colorectal Neoplasms; Combined Modality Therapy; Hepatectomy; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2019 |
Angiogenesis in
Topics: Colorectal Neoplasms; Humans; Liver Neoplasms; Neovascularization, Pathologic; Yttrium Radioisotopes | 2019 |
Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Embolization, Therapeutic; Evidence-Based Medicine; Humans; Liver Neoplasms; Salvage Therapy; Yttrium Radioisotopes | 2019 |
Trans-arterial Radioembolization Dosimetry in 2022.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Radiometry; Yttrium Radioisotopes | 2022 |
Role of Transhepatic Arterial Radioembolization in Metastatic Colorectal Cancer.
Topics: Brachytherapy; Colonic Neoplasms; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Metastasis; Rectal Neoplasms; Yttrium Radioisotopes | 2022 |
Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
Topics: Animals; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis.
Topics: Aged; Brachytherapy; Chemoembolization, Therapeutic; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2018 |
[Interventional radiological procedures in the therapy for colorectal liver metastases].
Topics: Angiography, Digital Subtraction; Brachytherapy; Catheter Ablation; Colorectal Neoplasms; Cooperative Behavior; Embolization, Therapeutic; Follow-Up Studies; Humans; Hyperthermia, Induced; Interdisciplinary Communication; Liver Neoplasms; Magnetic Resonance Imaging; Outcome and Process Assessment, Health Care; Radiology, Interventional; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.
Topics: Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Humans; Liver Neoplasms; Prognosis; Safety; Salvage Therapy; Yttrium Radioisotopes | 2014 |
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Y90 selective internal radiation therapy.
Topics: Brachytherapy; Colorectal Neoplasms; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2015 |
Y-90 Radiomicrosphere Therapy for Colorectal Cancer Liver Metastases.
Topics: Animals; Colorectal Neoplasms; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2016 |
Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?
Topics: Chemoembolization, Therapeutic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Humans; Liver Neoplasms; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retreatment; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Selective internal radiation therapy for liver metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Disease-Free Survival; Fluorouracil; Hepatic Artery; Humans; Leucovorin; Liver Neoplasms; Microspheres; Organoplatinum Compounds; Quality of Life; Yttrium Radioisotopes | 2016 |
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Glass; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Microspheres; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Selective internal radiation therapy for liver metastases from colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Floxuridine; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Microspheres; Radiotherapy; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2009 |
Liver metastases from colorectal cancer: radioembolization with systemic therapy.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2009 |
State of the art: radiolabeled microspheres treatment for liver malignancies.
Topics: Carcinoma, Hepatocellular; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Radiation-Sensitizing Agents; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2010 |
A serious complication of selected internal radiation therapy: case report and literature review.
Topics: Adenocarcinoma; Colorectal Neoplasms; Gastric Mucosa; Humans; Male; Middle Aged; Radiation Injuries; Stomach Ulcer; Yttrium Radioisotopes | 2010 |
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Glass; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Microspheres; Resins, Synthetic; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2012 |
Arterial therapies of colorectal cancer metastases to the liver.
Topics: Angiography, Digital Subtraction; Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Radiography, Interventional; Salvage Therapy; Yttrium Radioisotopes | 2011 |
Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?
Topics: Antineoplastic Agents; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Yttrium Radioisotopes | 2012 |
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Carcinoembryonic Antigen; Colorectal Neoplasms; Combined Modality Therapy; Feasibility Studies; Fluorouracil; Humans; Maximum Tolerated Dose; Radioimmunotherapy; Recombinant Fusion Proteins; Yttrium Radioisotopes | 2003 |
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Topics: Algorithms; Autopsy; Biopsy; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Colonic Neoplasms; Colorectal Neoplasms; Female; Humans; Liver; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Radiotherapy Dosage; Yttrium Radioisotopes | 2004 |
Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
Topics: Adenocarcinoma; Algorithms; Brachytherapy; Cell Hypoxia; Colorectal Neoplasms; Humans; Liver; Liver Neoplasms; Microspheres; Radiation Injuries; Radiotherapy Dosage; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2006 |
[Developments and perspectives in radioablative techniques].
Topics: Antineoplastic Agents; Brachytherapy; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Microspheres; Neoplasms; Radiation-Sensitizing Agents; Radiography; Radiology, Interventional; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2007 |
Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2008 |
31 trial(s) available for yttrium radioisotopes and Colorectal Neoplasms
| Article | Year |
|---|---|
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in Fra
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Prospective Studies; Quality of Life; Registries; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Colorectal Neoplasms; Fatigue; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Quality of Life; Surveys and Questionnaires; Vomiting; Yttrium Radioisotopes | 2020 |
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Case-Control Studies; Chemoradiotherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Oxaliplatin; Prognosis; Survival Rate; Yttrium Radioisotopes | 2021 |
Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization-a prospective, within-patient randomized study.
Topics: Catheters; Colorectal Neoplasms; Embolization, Therapeutic; Holmium; Humans; Liver Neoplasms; Prospective Studies; Radioisotopes; Yttrium Radioisotopes | 2021 |
Topics: Adult; Aged; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Iohexol; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres.
Topics: Adolescent; Adult; Aged; Colorectal Neoplasms; Composite Resins; Embolization, Therapeutic; Female; Genes, bcl-2; Genes, p53; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Survivin; Tumor Suppressor Protein p53; Young Adult; Yttrium Radioisotopes | 2013 |
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Colorectal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Yttrium Radioisotopes | 2014 |
FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-on
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Radiation-Sensitizing Agents; Radiotherapy; Yttrium Radioisotopes | 2014 |
Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Safety; Salvage Therapy; Survival Rate; Yttrium Radioisotopes | 2015 |
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Microspheres; Organoplatinum Compounds; Yttrium Radioisotopes | 2014 |
KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Disease-Free Survival; Female; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Male; Middle Aged; Pennsylvania; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sex Distribution; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
Topics: Aged; Cohort Studies; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Female; Glycolysis; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Radiometry; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2016 |
Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; DNA; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microscopy, Atomic Force; Middle Aged; Proto-Oncogene Proteins p21(ras); Retrospective Studies; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
Topics: Aged; Aged, 80 and over; Chemoembolization, Therapeutic; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Survival Analysis; Yttrium Radioisotopes | 2009 |
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Quality of Life; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2010 |
The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2011 |
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Camptothecin; Chemoradiotherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Carcinoembryonic Antigen; Colorectal Neoplasms; Combined Modality Therapy; Feasibility Studies; Fluorouracil; Humans; Maximum Tolerated Dose; Radioimmunotherapy; Recombinant Fusion Proteins; Yttrium Radioisotopes | 2003 |
Technology evaluation: cT84.66, City of Hope.
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Humans; Immunoglobulin G; Male; Radioimmunotherapy; Structure-Activity Relationship; Yttrium Radioisotopes | 2004 |
Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glass; Humans; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Trauma Severity Indices; Treatment Outcome; Yttrium Radioisotopes | 2004 |
Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.
Topics: Adenocarcinoma; Aged; Australia; Carcinoma, Hepatocellular; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Australia; Brachytherapy; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Maximum Tolerated Dose; Microspheres; Middle Aged; Organoplatinum Compounds; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; United Kingdom; Vitamin B Complex; Yttrium Radioisotopes | 2007 |
Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Survival Analysis; Yttrium Radioisotopes | 2007 |
Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Humans; Immunoglobulin G; Male; Middle Aged; Radioimmunotherapy; Recombinant Fusion Proteins; Yttrium Radioisotopes | 1995 |
Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.
Topics: Adult; Aged; Brachytherapy; Colorectal Neoplasms; Female; Follow-Up Studies; Glass; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Radionuclide Imaging; Radiotherapy Dosage; Technetium Tc 99m Aggregated Albumin; Time Factors; Yttrium Radioisotopes | 1994 |
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Immunoglobulin G; Liver; Lung Neoplasms; Mice; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Thyroid Neoplasms; Time Factors; Yttrium Radioisotopes | 2000 |
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Floxuridine; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Quality of Life; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2001 |
Radioembolization for hepatic metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2002 |
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
144 other study(ies) available for yttrium radioisotopes and Colorectal Neoplasms
| Article | Year |
|---|---|
Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Treatment Outcome; Yttrium Radioisotopes | 2022 |
MR Imaging Volumetric Response after Yttrium-90 Radioembolization for Colorectal Liver Metastases: Predictability at Baseline and Correlation with Survival.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Europe; Humans; Liver Neoplasms; Microspheres; Quality of Life; Yttrium Radioisotopes | 2023 |
Gastric Ulceration after Yttrium-90 Radiation Segmentectomy of Colorectal Cancer Metastases.
Topics: Colorectal Neoplasms; Humans; Liver Neoplasms; Microspheres; Pneumonectomy; Stomach Ulcer; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Predictive Partition Dosimetry and Outcomes after Yttrium-90 Resin Microsphere Radioembolization of Colorectal Cancer Metastatic to the Liver: A Retrospective Analysis.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Microspheres; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2023 |
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colorectal Neoplasms; Embolization, Therapeutic; Feasibility Studies; Humans; Liver Neoplasms; Microsatellite Repeats; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Posterior Reversible Encephalopathy Syndrome After 90Y-Resin Microspheres Radioembolization.
Topics: Aged; Brachytherapy; Colorectal Neoplasms; Diagnosis, Differential; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Posterior Leukoencephalopathy Syndrome; Radiopharmaceuticals; Seizures; Yttrium Radioisotopes | 2020 |
Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Male; Microspheres; Middle Aged; Progression-Free Survival; Retrospective Studies; Salvage Therapy; Yttrium Radioisotopes | 2020 |
A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Humans; Microspheres; Quality-Adjusted Life Years; State Medicine; United Kingdom; Yttrium Radioisotopes | 2020 |
Efficacy of 90Y-Radioembolization in Metastatic Colorectal Cancer Depending on the Primary Tumor Side.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2021 |
Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
Topics: Aged; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Prognosis; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2020 |
Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
Topics: Aged; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Progression-Free Survival; Response Evaluation Criteria in Solid Tumors; Salvage Therapy; Yttrium Radioisotopes | 2021 |
Survival Advantage of Yttrium-90 Radioembolization to Systemic Therapy in Patients with Hepatic Metastases from Colorectal Cancer in the Salvage Setting: Results of a Matched Pair Study.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Two Tumors, One Target: Preliminary Experience With 90Y-FAPI Therapy in a Patient With Metastasized Breast and Colorectal Cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Humans; Positron Emission Tomography Computed Tomography; Yttrium Radioisotopes | 2021 |
A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Retreatment; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2017 |
Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
Topics: Antimetabolites, Antineoplastic; Brachytherapy; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Female; Floxuridine; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2018 |
Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience.
Topics: Adult; Brachytherapy; Chemoembolization, Therapeutic; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2019 |
The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
Topics: Adult; Aged; Colorectal Neoplasms; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Phantoms, Imaging; Radiometry; Single Photon Emission Computed Tomography Computed Tomography; Yttrium Radioisotopes | 2018 |
Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiation Dosage; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate; Young Adult; Yttrium Radioisotopes | 2019 |
Transarterial Radiation Lobectomy, Portal Vein Embolization, and Staged Hepatectomy for Multiple Bilobar Metachronous Colorectal Liver Metastasis.
Topics: Angiography; Colorectal Neoplasms; Embolization, Therapeutic; Hepatectomy; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Portal Vein; Yttrium Radioisotopes | 2018 |
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2019 |
Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Yttrium Radioisotopes | 2019 |
Radiosensitivity of colorectal cancer to
Topics: Beta Particles; Colorectal Neoplasms; Embolization, Therapeutic; Gamma Rays; Humans; Monte Carlo Method; Radiation Tolerance; Radiobiology; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes | 2019 |
Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Prognosis; Proto-Oncogene Proteins p21(ras); Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2021 |
Locoregional Liver-Directed Therapies to Treat Unresectable Colorectal Liver Metastases: A Review
Topics: Antineoplastic Agents; Chemoembolization, Therapeutic; Colorectal Neoplasms; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Radiosurgery; Yttrium Radioisotopes | 2022 |
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Registries; Yttrium Radioisotopes | 2022 |
The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of
Topics: Aged; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiobiology; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2020 |
Impact of Genomic Mutation and Timing of Y90 Radioembolization in Colorectal Liver Metastases.
Topics: Aged; Brachytherapy; Case-Control Studies; Colorectal Neoplasms; Female; Genomics; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Retrospective Studies; Survival Analysis; Time Factors; Tumor Burden; Yttrium Radioisotopes | 2020 |
Topics: Aged; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Middle Aged; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Editorial Comment: Primary Tumor Location Is a Significant Prognostic Factor of Survival After
Topics: Brachytherapy; Colorectal Neoplasms; Humans; Prognosis; Yttrium Radioisotopes | 2021 |
A new in vitro model applied
Topics: Beta Particles; Cell Proliferation; Colorectal Neoplasms; HCT116 Cells; Humans; Hypoxia; Microspheres; Mitochondria; Radiometry; Yttrium Radioisotopes | 2021 |
Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?
Topics: Carcinoma, Hepatocellular; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2021 |
Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Topics: Adult; Aged; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Tumor Burden; Yttrium Radioisotopes | 2017 |
Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Chemoradiotherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.
Topics: Academic Medical Centers; Aspartate Aminotransferases; Carcinoembryonic Antigen; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neutrophils; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden; United States; Yttrium Radioisotopes | 2018 |
Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Muscle, Skeletal; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Yttrium Radioisotopes | 2019 |
Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
Topics: Adult; Aged; Biological Transport; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Predictive Value of Tests; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2013 |
The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver; Liver Neoplasms; Microspheres; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radiometry; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2013 |
The importance of anatomy in a new iatrogenic disease: yttrium microsphere-induced gastritis.
Topics: Colorectal Neoplasms; Gastritis; Humans; Iatrogenic Disease; Liver Neoplasms; Male; Microspheres; Middle Aged; Yttrium Radioisotopes | 2013 |
Y90-radioembolization of lung metastases via the bronchial artery: a report of 2 cases.
Topics: Aged; Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Feasibility Studies; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Microspheres; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
Topics: Aged; Colorectal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Yttrium Radioisotopes | 2013 |
Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiometry; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2013 |
General theory of predictive dosimetry for yttrium-90 radioembolization to sites other than the liver.
Topics: Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Multimodal Imaging; Splenomegaly; Yttrium Radioisotopes | 2014 |
General theory of predictive dosimetry for yttrium-90 radioembolization to sites other than the liver: reply.
Topics: Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Yttrium Radioisotopes | 2014 |
Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.
Topics: Adult; Aged; Aged, 80 and over; Angiogenic Proteins; Biomarkers, Tumor; Carcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Cytokines; Embolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neovascularization, Pathologic; Pilot Projects; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Resins, Synthetic; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
Topics: Aged; Carcinoma; Chemoradiotherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Survival Analysis; Yttrium Radioisotopes | 2014 |
Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection.
Topics: Adult; Aged; Brachytherapy; Catheters; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2015 |
PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
Topics: Adenocarcinoma; Aged; Brachytherapy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Computer Simulation; Embolization, Therapeutic; Esophageal Neoplasms; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Phantoms, Imaging; Positron-Emission Tomography; Radiation Dosage; Signal-To-Noise Ratio; Tissue Distribution; Yttrium Radioisotopes | 2014 |
Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphocytes; Male; Middle Aged; Neoplasm Staging; Neutrophils; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2015 |
Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2015 |
Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm.
Topics: Brachytherapy; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Humans; Liver Neoplasms; Prognosis; Safety; Salvage Therapy; Yttrium Radioisotopes | 2015 |
Yttrium-90 Radioembolization as Salvage Therapy for Liver Metastases From Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Salvage Therapy; Survival Rate; Yttrium Radioisotopes | 2017 |
Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urologic Neoplasms; Yttrium Radioisotopes | 2015 |
Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2015 |
Outcomes of Therasphere Radioembolization for Colorectal Metastases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK.
Topics: Aged; Colorectal Neoplasms; Cost-Benefit Analysis; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Quality-Adjusted Life Years; Retrospective Studies; Salvage Therapy; Survival Analysis; United Kingdom; Yttrium Radioisotopes | 2015 |
90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pulmonary Ventilation; Radionuclide Imaging; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tumor Burden; Yttrium Radioisotopes | 2016 |
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2015 |
Evaluation of Liver Biomarkers as Prognostic Factors for Outcomes to Yttrium-90 Radioembolization of Primary and Secondary Liver Malignancies.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based 90Y Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the Liver.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Yttrium Radioisotopes | 2016 |
Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
Topics: Animals; Antibodies, Bispecific; Antibody Affinity; Colorectal Neoplasms; Immunoconjugates; Immunoglobulin G; Lutetium; Membrane Glycoproteins; Mice; Radioimmunotherapy; Radiopharmaceuticals; Single-Chain Antibodies; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2016 |
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival.
Topics: Aged; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Hypertension, Portal; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes | 2016 |
90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
Topics: Aged; Colorectal Neoplasms; Embolization, Therapeutic; Female; Glass; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Radiometry; Retrospective Studies; Safety; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2016 |
The role of radioembolization in colorectal cancer treatment.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiosurgery; Yttrium Radioisotopes | 2016 |
Robust evidence for long-term survival with
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Camptothecin; Chemoembolization, Therapeutic; Colorectal Neoplasms; Doxorubicin; Embolization, Therapeutic; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Retrospective Studies; Yttrium Radioisotopes | 2016 |
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Analysis; Tumor Burden; Yttrium Radioisotopes | 2016 |
Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Iohexol; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Predictive Value of Tests; Retrospective Studies; ROC Curve; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2016 |
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
Topics: Adult; Aged; CA-19-9 Antigen; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Yttrium Radioisotopes | 2016 |
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with
Topics: Adenocarcinoma; Adult; Aged; Angiography; Arteriovenous Fistula; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver; Lung; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Eye Neoplasms; Hepatectomy; Humans; Length of Stay; Liver Neoplasms; Melanoma; Middle Aged; Neuroendocrine Tumors; Patient Readmission; Postoperative Complications; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2017 |
Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis.
Topics: Aged; Brachytherapy; Colorectal Neoplasms; Contrast Media; Drug Delivery Systems; Embolization, Therapeutic; Female; Humans; Iopamidol; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Treatment Outcome; Water; Yttrium Radioisotopes | 2017 |
Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Topics: Antineoplastic Agents; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Failure; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres.
Topics: Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Humans; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Liver Neoplasms; Microspheres; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiation Dosage; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoembolization, Therapeutic; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible?
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Neuroendocrine; Catheter Ablation; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2010 |
Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.
Topics: Adult; Aged; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Liver; Liver Neoplasms; Lung; Male; Microspheres; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2009 |
Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT.
Topics: Brachytherapy; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2009 |
Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases.
Topics: Colorectal Neoplasms; Disease Progression; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiography, Interventional; Radiotherapy Dosage; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
Topics: Adult; Carcinoma, Adenosquamous; Cholangiocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Gastrinoma; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Radiotherapy; Registries; Sarcoma; Treatment Outcome; Yttrium Radioisotopes | 2011 |
PET/CT for the assessment and quantification of (90)Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases.
Topics: Brachytherapy; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2010 |
(90)Y radioembolization: embolization of the gastroduodenal artery is not always appropriate.
Topics: Angiography; Catheterization; Colorectal Neoplasms; Contrast Media; Duodenum; Embolization, Therapeutic; Follow-Up Studies; Hepatic Artery; Humans; Liver Neoplasms; Male; Mesenteric Arteries; Middle Aged; Neoplasm Staging; Palliative Care; Stomach; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes | 2010 |
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Colorectal Neoplasms; Female; Humans; Immunoconjugates; Isothiocyanates; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radioimmunoassay; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Yttrium Radioisotopes | 2011 |
Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy.
Topics: Adult; Aged; Brachytherapy; Colorectal Neoplasms; Combined Modality Therapy; Diffusion Magnetic Resonance Imaging; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Yttrium Radioisotopes | 2010 |
Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Radiotherapy, Adjuvant; Yttrium Radioisotopes | 2010 |
A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Yttrium Radioisotopes | 2011 |
Liver radioembolization using 90Y resin microspheres in elderly patients: tolerance and outcome.
Topics: Aged; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Microspheres; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Yttrium Radioisotopes | 2010 |
Model-based radiation dose correction for yttrium-90 microsphere treatment of liver tumors with central necrosis.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Models, Biological; Monte Carlo Method; Necrosis; Radionuclide Imaging; Radiotherapy Dosage; Technology, Radiologic; Tumor Burden; Yttrium Radioisotopes | 2011 |
Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.
Topics: Adult; Aged; Angiography; Carcinoma, Hepatocellular; Colorectal Neoplasms; Embolization, Therapeutic; Feasibility Studies; Female; Gallbladder; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Radiation Injuries; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
What, how, and when to offer nonresectional therapy for colorectal cancer liver metastases.
Topics: Ablation Techniques; Antineoplastic Agents; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Radiosurgery; Yttrium Radioisotopes | 2011 |
Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Neoplasm; Colorectal Neoplasms; Female; Humans; Immunotoxins; Indium Radioisotopes; Male; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Tissue Distribution; Yttrium Radioisotopes | 2011 |
Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Brachytherapy; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases.
Topics: Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2012 |
[Intra-arterial treatment of liver metastases from colorectal carcinoma].
Topics: Chemoembolization, Therapeutic; Colorectal Neoplasms; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Yttrium Radioisotopes | 2011 |
Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Collateral Circulation; Colorectal Neoplasms; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Neovascularization, Pathologic; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Blotting, Western; Cadherins; Cell Line, Tumor; Colorectal Neoplasms; Female; Flow Cytometry; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2012 |
Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Yttrium Radioisotopes | 2012 |
Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Neoplasms; Male; Microspheres; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2012 |
Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases.
Topics: Adenocarcinoma; Antineoplastic Agents; Brachytherapy; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Microspheres; Radiography; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.
Topics: Adult; Aged; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Resins, Synthetic; Retrospective Studies; Risk Assessment; Risk Factors; Salvage Therapy; Tomography, X-Ray Computed; Treatment Failure; Yttrium Radioisotopes | 2014 |
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Topics: Animals; Antibodies, Monoclonal; Colorectal Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Iodine Radioisotopes; Lutetium; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Specificity; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Rhenium; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes | 2004 |
Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Liver Neoplasms; Microspheres; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Benzamides; Colorectal Neoplasms; Female; Humans; Imatinib Mesylate; Immunotoxins; Iodine Radioisotopes; Mice; Mice, Nude; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radioimmunotherapy; Receptor, Platelet-Derived Growth Factor beta; Swine; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2005 |
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Salvage Therapy; Survival Analysis; Yttrium Radioisotopes | 2006 |
Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2006 |
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
Topics: Aged; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Salvage Therapy; Yttrium Radioisotopes | 2007 |
Selective internal radiation therapy: a case of SIR-Sphere associated duodenal ulceration.
Topics: Adenocarcinoma; Brachytherapy; Colorectal Neoplasms; Duodenal Ulcer; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Yttrium Radioisotopes | 2007 |
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cetuximab; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques.
Topics: Algorithms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2008 |
Adjuvant internal radiation therapy in a model of colorectal cancer-derived hepatic metastases.
Topics: Animals; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Female; Injections, Intravenous; Liver; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Neoplasm Transplantation; Portal Vein; Radiotherapy, Adjuvant; Random Allocation; Rats; Rats, Wistar; Yttrium Radioisotopes | 1995 |
Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.
Topics: Amino Acid Sequence; Animals; CHO Cells; Cloning, Molecular; Colorectal Neoplasms; Cricetinae; DNA, Complementary; Drug Screening Assays, Antitumor; Gene Expression; Genes, Immunoglobulin; Humans; Hybridomas; Immunoconjugates; Immunoglobulin Fragments; Immunoglobulin G; Indium Radioisotopes; Mice; Mice, Nude; Molecular Sequence Data; Multiple Myeloma; Neoplasm Transplantation; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1995 |
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Drug Carriers; Female; HL-60 Cells; Humans; Immunoconjugates; Indium Radioisotopes; Iodine Radioisotopes; Liposomes; Radioimmunotherapy; Sialic Acid Binding Ig-like Lectin 3; Yttrium Radioisotopes | 1996 |
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Cell Division; Colorectal Neoplasms; Female; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Leukocyte Count; Metabolic Clearance Rate; Mice; Mice, Nude; Radioimmunotherapy; Time Factors; Tissue Distribution; Transplantation, Heterologous; Weight Loss; Yttrium Radioisotopes | 1996 |
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Topics: Animals; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Iodine Radioisotopes; Mice; Mice, Nude; Radioimmunotherapy; Transplantation, Heterologous; Yttrium Radioisotopes | 1996 |
Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Humans; Liver; Liver Neoplasms; Microspheres; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 1997 |
Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle.
Topics: Animals; Antibodies, Neoplasm; Colorectal Neoplasms; Drug Therapy, Combination; Heterocyclic Compounds; Humans; Immunoglobulin G; Mice; Neoplasm Transplantation; Radioimmunotherapy; Tissue Distribution; Yttrium Radioisotopes | 1998 |
Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Immunoglobulin Fab Fragments; Mice; Mice, Nude; Radiation Dosage; Radioimmunotherapy; Radiometry; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1999 |
CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Colorectal Neoplasms; Edetic Acid; Female; Humans; In Vitro Techniques; Indium Radioisotopes; Mice; Mice, Nude; Radioimmunodetection; Radioimmunotherapy; Tumor Cells, Cultured; Yttrium Radioisotopes | 2000 |
A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor.
Topics: Animals; Beta Particles; Colorectal Neoplasms; Disease Models, Animal; Humans; Immunoconjugates; Iodine Radioisotopes; Kidney; Mice; Mice, Nude; Neoplasm Transplantation; Radiotherapy Dosage; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2001 |
Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Carbon Radioisotopes; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Immunoconjugates; Immunoglobulin G; Iodine Radioisotopes; Luminescent Measurements; Mice; Mice, Nude; Neoplasms; Radioimmunodetection; Radioimmunotherapy; Radiometry; Radiotherapy Dosage; Sensitivity and Specificity; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 2001 |
Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Colorectal Neoplasms; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasm Transplantation; Radiation Tolerance; Radioimmunotherapy; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 2002 |
Glass yttrium-90 microspheres for patients with colorectal liver metastases.
Topics: Angiotensin II; Colorectal Neoplasms; Glass; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Microspheres; Middle Aged; Radiotherapy Dosage; Yttrium Radioisotopes | 1992 |
Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
Topics: Amifostine; Animals; Antibodies, Monoclonal; Cell Division; Cell Line; Chelating Agents; Colorectal Neoplasms; Female; Hemoglobins; Humans; Immunotherapy; Mice; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Transplantation, Heterologous; Yttrium Radioisotopes | 1990 |
Estimation of monoclonal antibody-associated 90Y activity needed to achieve certain tumor radiation doses in colorectal cancer patients.
Topics: Antibodies, Monoclonal; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Radiotherapy Dosage; Yttrium Radioisotopes | 1990 |
Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate.
Topics: Adenocarcinoma; Brachytherapy; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Humans; Liver Neoplasms; Yttrium Radioisotopes | 1989 |
Hepatic malignancies: improved treatment with intraarterial Y-90.
Topics: Aged; Brachytherapy; Colorectal Neoplasms; Female; Follow-Up Studies; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Radiotherapy Dosage; Time Factors; Yttrium Radioisotopes | 1988 |
Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinoma.
Topics: Animals; Antibodies, Monoclonal; Colorectal Neoplasms; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1988 |